Gina Mazzariello, Chief Legal Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 12,328 shares at $20.88 ($257K) on 2023-08-15, disclosed to the SEC on 2023-08-17.
Scheduled sale ($257k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.88 | 6,164 | $129K | 50.0% |
| 2 | $20.88 | 6,164 | $129K | 50.0% |
| Total | $20.88 avg | 12,328 | $257K | 100% |
| Filing → |
| AMLX | SELL | 2026-03-04 | $99K | — | Filing → |
| AMLX | SELL | 2026-02-25 | $48K | — | Filing → |
| AMLX | SELL | 2026-02-04 | $51K | — | Filing → |